|
Eli Lilly
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$1034
|
$958B |
15.4x |
34.4x |
|
Johnson & Johnson
|
United States of America |
Biopharmaceuticals,
Medical Devices,
Drug Development & Therapeutics
|
$205
|
$522B |
5.6x |
14.7x |
|
AbbVie
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
$224
|
$460B |
7.6x |
17.9x |
|
Roche
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Imaging & Diagnostics
|
CHF 315
|
$339B |
4.4x |
11.1x |
|
AstraZeneca
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
£138
|
$307B |
5.3x |
15.3x |
|
Novartis
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 107
|
$279B |
5.0x |
12.3x |
|
Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$101
|
$274B |
4.2x |
9.4x |
|
Thermo Fisher Scientific
|
United States of America |
Laboratory Services,
Medical Devices,
Medical Supplies
|
$580
|
$250B |
5.7x |
22.5x |
|
Amgen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$338
|
$227B |
6.3x |
12.7x |
|
Novo Nordisk
|
Denmark |
Biopharmaceuticals,
Drug Development & Therapeutics
|
DKK 307
|
$223B |
4.7x |
9.6x |
|
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$25
|
$189B |
3.0x |
7.6x |
|
Danaher
|
United States of America |
Medical Devices,
Laboratory Services,
Medical Supplies
|
$228
|
$177B |
7.2x |
23.2x |
|
Gilead Sciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$125
|
$173B |
5.9x |
11.1x |
|
Bristol-Myers Squibb
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$51
|
$138B |
2.9x |
7.8x |
|
Sanofi
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€86
|
$130B |
2.5x |
8.3x |
|
GSK
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£18
|
$116B |
2.7x |
8.0x |
|
Vertex Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Regenerative Medicine
|
$433
|
$105B |
8.8x |
20.8x |
|
Chugai Pharmaceutical Co
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 8213
|
$81.1B |
10.2x |
20.0x |
|
Bayer
|
Germany |
Biopharmaceuticals,
Agriculture,
Drug Development & Therapeutics,
Health & Beauty
|
€34
|
$76.9B |
1.4x |
6.9x |
|
Regeneron Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$724
|
$70.3B |
4.9x |
13.9x |
|
Takeda Pharmaceuticals
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 4454
|
$70.2B |
2.4x |
9.1x |
|
Merck KGaA
|
Germany |
Biopharmaceuticals,
Drug Development & Therapeutics,
Advanced Materials
|
€117
|
$69.7B |
2.8x |
9.9x |
|
CSL
|
Australia |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
AUD 182
|
$67.5B |
4.3x |
12.6x |
|
Zoetis
|
United States of America |
Pet Care,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$124
|
$60.0B |
6.4x |
14.6x |
|
Alnylam Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$465
|
$60.0B |
16.6x |
91.1x |
|
IDEXX Laboratories
|
United States of America |
Medical Devices,
Laboratory Services,
Healthcare Software
|
$726
|
$58.9B |
13.8x |
39.8x |
|
UCB
|
Belgium |
Vaccines & Immunotherapies
|
€243
|
$54.7B |
6.6x |
22.0x |
|
Haleon
|
United Kingdom of Great Britain and Northern Ireland |
Health & Beauty,
Drug Development & Therapeutics
|
£4
|
$53.7B |
3.7x |
14.6x |
|
Lonza Group
|
Switzerland |
Contract Research & Manufacturing,
Biopharmaceuticals
|
CHF 554
|
$53.0B |
5.7x |
19.3x |
|
argenx
|
Belgium |
Drug Development & Therapeutics
|
€781
|
$52.0B |
12.7x |
47.5x |
|
IQVIA
|
United States of America |
Contract Research & Manufacturing,
Health Data & Analytics,
Healthcare Software
|
$227
|
$51.9B |
3.2x |
13.8x |
|
Jiangsu Hengrui Pharma
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 61
|
$51.7B |
11.1x |
37.2x |
|
Samsung BioLogics
|
South Korea |
Contract Research & Manufacturing
|
KRW 1654000
|
$51.6B |
13.3x |
28.3x |
|
Galderma Group
|
Switzerland |
Health & Beauty,
Drug Development & Therapeutics
|
CHF 163
|
$50.1B |
9.7x |
42.3x |
|
Teva Pharmaceuticals
|
Israel |
Biopharmaceuticals,
Drug Development & Therapeutics
|
ILS 89
|
$46.3B |
2.7x |
9.1x |
|
Sun Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1807
|
$45.5B |
7.3x |
25.7x |
|
Agilent
|
United States of America |
Laboratory Services,
Medical Devices,
Medical Imaging & Diagnostics
|
$149
|
$43.8B |
6.4x |
21.7x |
|
Fresenius
|
Germany |
Hospitals & Clinics,
Medical Supplies,
Drug Development & Therapeutics
|
€47
|
$43.5B |
1.7x |
9.9x |
|
Insmed
|
United States of America |
Drug Development & Therapeutics
|
$207
|
$43.0B |
86.2x |
-38.1x |
|
Daiichi Sankyo
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 3561
|
$39.8B |
3.1x |
14.8x |
|
Sandoz
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 57
|
$35.0B |
3.2x |
14.7x |
|
BeOne Medicines
|
Hong Kong |
Drug Development & Therapeutics
|
HKD 205
|
$34.9B |
6.8x |
76.9x |
|
Wuxi AppTec
|
China |
Contract Research & Manufacturing,
Laboratory Services
|
CNY 88
|
$33.5B |
5.4x |
12.0x |
|
Natera
|
United States of America |
Genomics & Personalized Medicine,
Medical Imaging & Diagnostics
|
$237
|
$31.8B |
14.6x |
-100.2x |
|
Mettler Toledo
|
United States of America |
Laboratory Services,
Medical Devices
|
$1435
|
$31.5B |
7.9x |
25.2x |
|
Celltrion
|
South Korea |
Biopharmaceuticals
|
KRW 183300
|
$29.4B |
10.6x |
30.2x |
|
Biogen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$181
|
$29.1B |
3.0x |
9.5x |
|
Otsuka Holdings
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
JPY 9044
|
$28.7B |
1.9x |
7.7x |
|
Labcorp
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics
|
$266
|
$28.0B |
2.0x |
11.7x |
|
Hansoh Pharma
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 40
|
$26.9B |
13.1x |
34.2x |
|
Quest Diagnostics
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics
|
$183
|
$26.3B |
2.4x |
12.1x |
|
Sartorius Stedim Biotech
|
France |
Medical Devices,
Laboratory Services,
Contract Research & Manufacturing
|
€207
|
$26.0B |
7.6x |
24.9x |
|
Viatris
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$11
|
$26.0B |
1.8x |
6.3x |
|
Astellas Pharma
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 1984
|
$25.7B |
2.0x |
8.6x |
|
Waters
|
United States of America |
Laboratory Services,
Medical Devices
|
$398
|
$24.7B |
7.8x |
22.0x |
|
Royalty Pharma
|
United States of America |
Biopharmaceuticals
|
$40
|
$24.0B |
8.1x |
8.4x |
|
Bausch Health
|
Canada |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices,
Health & Beauty
|
CAD 10
|
$22.3B |
2.2x |
6.3x |
|
Insulet
|
United States of America |
Medical Devices,
Drug Delivery Systems
|
$309
|
$22.0B |
8.3x |
34.7x |
|
Illumina
|
United States of America |
Genomics & Personalized Medicine,
Laboratory Services
|
$128
|
$20.8B |
4.9x |
17.5x |
|
Sichuan Biokin
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 362
|
$20.8B |
58.7x |
38.8x |
|
Exact Sciences
|
United States of America |
Medical Imaging & Diagnostics,
Genomics & Personalized Medicine
|
$101
|
$20.7B |
6.5x |
45.8x |
|
Innovent Biologics
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 92
|
$19.3B |
10.5x |
77.8x |
|
Alteogen
|
South Korea |
Biopharmaceuticals
|
KRW 522000
|
$18.7B |
127.6x |
242.0x |
|
Divi's Laboratories
|
India |
Contract Research & Manufacturing,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
INR 6455
|
$18.7B |
16.4x |
50.5x |
|
United Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$481
|
$17.6B |
5.5x |
10.6x |
|
ICON plc
|
United States of America |
Contract Research & Manufacturing,
Healthcare Software,
Health Data & Analytics
|
$188
|
$17.4B |
2.2x |
11.0x |
|
Incyte
|
United States of America |
Drug Development & Therapeutics
|
$102
|
$17.0B |
3.5x |
11.5x |
|
Grifols
|
Spain |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€9
|
$16.9B |
1.9x |
8.0x |
|
Genmab
|
Denmark |
Drug Development & Therapeutics,
Biopharmaceuticals
|
DKK 2034
|
$16.2B |
4.5x |
11.8x |
|
Eurofins Scientific
|
France |
Laboratory Services,
Contract Research & Manufacturing
|
€59
|
$16.1B |
1.9x |
8.7x |
|
Medpace
|
United States of America |
Contract Research & Manufacturing,
Medical Devices
|
$576
|
$16.1B |
6.5x |
29.2x |
|
BridgeBio Pharma
|
United States of America |
Drug Development & Therapeutics
|
$74
|
$15.5B |
32.7x |
-33.3x |
|
Wuxi Biologics
|
Hong Kong |
Contract Research & Manufacturing
|
HKD 31
|
$15.3B |
5.0x |
14.4x |
|
Biomerieux
|
France |
Laboratory Services,
Medical Imaging & Diagnostics
|
€108
|
$14.9B |
3.1x |
12.8x |
|
Zhangzhou Pientzehuang
|
China |
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
CNY 171
|
$14.6B |
9.9x |
30.4x |
|
Elanco
|
United States of America |
Drug Development & Therapeutics
|
$22
|
$14.5B |
3.1x |
16.4x |
|
Guardant Health
|
United States of America |
Medical Imaging & Diagnostics,
Genomics & Personalized Medicine
|
$106
|
$14.5B |
15.2x |
-67.4x |
|
Neurocrine Biosciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$152
|
$14.5B |
5.1x |
21.8x |
|
Sino Biopharmaceutical
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 7
|
$14.4B |
3.1x |
11.6x |
|
Torrent Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 3721
|
$14.2B |
10.2x |
31.0x |
|
Revvity
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics,
Health Data & Analytics
|
$103
|
$14.1B |
5.0x |
16.7x |
|
Recordati
|
Italy |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€50
|
$14.1B |
4.7x |
12.5x |
|
Sobi
|
Sweden |
Biopharmaceuticals,
Drug Development & Therapeutics
|
SEK 338
|
$13.7B |
4.6x |
11.9x |
|
Akeso
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 118
|
$13.6B |
29.6x |
-1038.1x |
|
Jazz Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$167
|
$13.5B |
3.2x |
13.9x |
|
Summit Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$18
|
$13.4B |
N/A |
-13.9x |
|
Revolution Medicines
|
United States of America |
Drug Development & Therapeutics
|
$78
|
$13.2B |
4105.4x |
-12.1x |
|
Fosun Pharma
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
CNY 25
|
$12.9B |
2.2x |
12.5x |
|
Ascendis Pharma
|
Germany |
Drug Development & Therapeutics
|
€174
|
$12.7B |
N/A |
N/A |
|
Cipla
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1508
|
$12.4B |
3.9x |
16.1x |
|
Ionis Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$81
|
$12.4B |
14.1x |
-33.2x |
|
Madrigal Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$580
|
$12.4B |
13.9x |
-40.9x |
|
Kelun-Biotech
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 432
|
$12.3B |
44.9x |
-263.4x |
|
Yunnan Baiyao Group
|
China |
Biopharmaceuticals,
Health & Beauty
|
CNY 56
|
$12.2B |
2.1x |
14.3x |
|
CR Pharmaceutical
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics,
Pharmacies
|
HKD 5
|
$11.8B |
0.3x |
5.3x |
|
Dr. Reddy's Laboratories
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1281
|
$11.7B |
3.1x |
12.6x |
|
Charles River
|
United States of America |
Contract Research & Manufacturing,
Laboratory Services
|
$185
|
$11.5B |
2.9x |
12.1x |
|
Ipsen
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€123
|
$11.2B |
2.6x |
6.8x |
|
Financiere de Tubize
|
Belgium |
Biopharmaceuticals
|
€211
|
$10.9B |
N/A |
N/A |
|
Exelixis
|
United States of America |
Drug Development & Therapeutics
|
$43
|
$10.8B |
4.7x |
11.7x |